Marinus Pharmaceuticals (NASDAQ:MRNS) Coverage Initiated by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Marinus Pharmaceuticals (NASDAQ:MRNS – Free Report) in a report released on Sunday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Several other brokerages have also issued reports on MRNS. HC Wainwright reissued a “neutral” rating and set a $2.00 price objective on shares of Marinus […]

Mar 3, 2025 - 09:37

StockNews.com initiated coverage on shares of Marinus Pharmaceuticals (NASDAQ:MRNS – Free Report) in a report released on Sunday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Several other brokerages have also issued reports on MRNS. HC Wainwright reissued a “neutral” rating and set a $2.00 price objective on shares of Marinus […]